Tahata, Yuki
Hikita, Hayato
Takaki, Akinobu
Kurosaki, Masayuki
Matsuura, Kentaro
Yatsuhashi, Hiroshi
Kuroda, Hidekatsu
Ueno, Yoshiyuki
Maekawa, Shinya
Nakamura, Masato
Sakamori, Ryotaro
Kodama, Takahiro
Takehara, Tetsuo https://orcid.org/0000-0001-5036-3457
Funding for this research was provided by:
Gilead Sciences
Article History
Received: 5 April 2025
Accepted: 15 October 2025
First Online: 30 October 2025
Declarations
:
: Hayato Hikita received lecture fees from Gilead Sciences, Inc. Masayuki Kurosaki received lecture fees from Gilead Sciences, Inc, AbbVie, Eisai, and AstraZeneca. Masato Nakamura received research grants and lecture fees from AbbVie GK. Ryotaro Sakamori received lecture fees from Gilead Sciences, Inc. Takeda. Takahiro Kodama received lecture fees from AbbVie GK. and Gilead Sciences, Inc. Tetsuo Takehara received research grants and lecture fees from AbbVie GK. and Gilead Sciences, Inc. All other authors declare that they have no conflicts of interest to disclose.